Dibbanti HariKrishna Reddy (Dibbanti HariKrishnaReddy)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Traumatic Brain Injury

Subarachnoid Hemorrhage

Endoplasmic Reticulum

Lipopolysaccharide Induced

Top Venues

Fundamental & clinical pharmacology

Molecular neurobiology

Laboratory animal research

Inflammopharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Rishika Dhapola, Sneha Kumari, Prajjwal Sharma, Pramod KumarKushawaha, Dibbanti HariKrishna Reddy
Update on monkeypox virus infection: Focusing current treatment and prevention approaches. Fundamental & clinical pharmacology (2024)
Rishika Dhapola, Sneha Kumari, Prajjwal Sharma, Pramod KumarKushawaha, Dibbanti HariKrishna Reddy
Update on monkeypox virus infection: Focusing current treatment and prevention approaches. Fundamental & clinical pharmacology 38 (3) (2024)
Rishika Dhapola, Sneha Kumari, Prajjwal Sharma, Pramod KumarKushawaha, Dibbanti HariKrishna Reddy
Update on monkeypox virus infection: Focusing current treatment and prevention approaches. Fundamental & clinical pharmacology 38 (3) (2024)
Rishika Dhapola, Prajjwal Sharma, Sneha Kumari, Jasvinder Singh Bhatti, Dibbanti HariKrishna Reddy
Environmental Toxins and Alzheimer's Disease: a Comprehensive Analysis of Pathogenic Mechanisms and Therapeutic Modulation. Molecular neurobiology (2023)
Rishika Dhapola, Sneha Kumari, Prajjwal Sharma, Dibbanti HariKrishna Reddy
Insight into the emerging and common experimental in-vivo models of Alzheimer's disease. Laboratory animal research 39 (1) (2023)
Rishika Dhapola, Subhendu Shekhar Hota, Phulen Sarma, Anusuya Bhattacharyya, Bikash Medhi, Dibbanti HariKrishna Reddy
Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease. Inflammopharmacology 29 (6) (2021)
Rishika Dhapola, Phulen Sarma, Bikash Medhi, Ajay Prakash, Dibbanti HariKrishna Reddy
Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease. Molecular neurobiology (2021)